Global Neurological Biomarkers Market to Grow at a CAGR of 15.48% During 2016-2020 - Key Vendors (Myriad RBM, Proteome Sciences, QIAGEN and Thermo Fisher Scientific)
Biomarkers are the indicators considered for identifying specific diseases. They are mainly used for identification of the progress of a particular disease and evaluation of an effective method for drug target identification. The biomarkers specifically involved in the identification of the neurological disorders are called neurological biomarkers.
View full press release